Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions

Human Pathology

Volumn 33, Issue 11, 2002, Pages 1069-1077

  Kumazaki, Kaori ^a   Nakayama, Masahiro ^a   Suehara, Noriyuki ^a   Wada, Yoshinao ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

Fms like tyrosine kinase; Kinase insert domain containing region; Pathologic placenta; Placental growth factor; Vascular endothelial growth factor

Indexed keywords

FORMALDEHYDE; GROWTH FACTOR; MESSENGER RNA; PARAFFIN; PARALDEHYDE; RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL; CELL MIGRATION; CHORIOAMNIONITIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; ISCHEMIA; MACROPHAGE; NEUTROPHIL CHEMOTAXIS; PLACENTA DISORDER; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

EID: 0036858714     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.129420     Document Type: Article

References (24)

1. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18:4-25, 1997
2. Dvorak HF, Brown LF, Detmar M, et al: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995
3. Alon T, Hemo I, Itin A, et al: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028, 1995
4. Clauss M, Gerlach M, Gerlach H, et al: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med Dec 172:1535-1545, 1990
5. Maglione D, Guerriero V, Viglietto G, et al: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 88:9267-9271, 1991
6. Park JE, Chen HH, Winer J, et al: Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646-25654, 1994
7. Shweiki D, Itin A, Soffer D, et al: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-835, 1992
8. Brogi E, Schatteman G, Wu T, et al: Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97:469-476, 1996
9. Gerber HP, Condorelli F, Park J, et al: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272:23659-23667, 1997
10. Ahmed A, Li XF, Dunk C, et al: Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12:235-243, 1995
11. Khaliq A, Li XF, Shams M, et al: Localisation of placenta growth factor (P1GF) in human term placenta. Growth Factors 13: 243-250, 1996
12. Vuorela P, Hatva E, Lymboussaki A, et al: Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56:489-494, 1997
13. Clark DE, Smith SK, Licence D, et al: Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 159:459-467, 1998
14. Khaliq A, Dunk C, Jiang J, et al: Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: Molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 79:151-170, 1999
15. Helske S, Vuorela P, Carpen O, et al: Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 7:205-210, 2001
16. Benirschke K, Kaufmann P: Pathology of the Human Placenta (Ed 4). New York, NY, Springer-Verlag, 2000
17. Fox H: Pathology of the Placenta (Ed 2). Philadelphia, PA, Saunders, 1997
18. Boocock CA, Charnock-Jones DS, Sharkey AM, et al: Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87:506-516, 1995
19. Altshuler G: Role of the placenta in perinatal pathology (revisited). Pediatr Pathol Lab Med 16:207-333, 1996
20. Altshuler G: Placental insight into neurodevelopmental and other childhood disease. Semin Pediatr Neurol 2:90-99, 1995
21. Shore VH, Wang TH, Wang CL, et al: Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18:657-665, 1997
22. Carmeliet P, Moons L, Luttun A, et al: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583, 2001
23. Barleon B, Sozzani S, Zhou D, et al: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343, 1996
24. Kumazaki K, Nakayama M, Sumida Y, et al: Placental features in preterm infants with periventricular leukomalacia. Pediatrics 109: 650-655, 2002